Oxyphencyclimine Hydrochloride

CAS No. 125-52-0

Oxyphencyclimine Hydrochloride( —— )

Catalog No. M17223 CAS No. 125-52-0

Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 48 In Stock
10MG 85 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Oxyphencyclimine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
  • Description
    Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Muscarinic AChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    125-52-0
  • Formula Weight
    380.91
  • Molecular Formula
    C20H29ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(c(cc1CNC[C@@H](c1c2ccc(=O)[nH]c2c(cc1)O)O)Cl)NC(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Waelbroeck M, et al. Eur J Pharmacol. 1992 Sep 1;227(1):33-42.
molnova catalog
related products
  • Y06137

    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

  • FHT-1015

    FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.

  • PBRM1-BD2-IN-5

    PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, with dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5 respectively, and an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2.